Biological Psychiatry
Volume 63, Issue 7 , Pages 678-685 , 1 April 2008

Gene and Expression Analyses Reveal Enhanced Expression of Pericentrin 2 (PCNT2) in Bipolar Disorder

  • Ayyappan Anitha

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Kazuhiko Nakamura

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • Corresponding Author InformationAddress reprint requests to Kazuhiko Nakamura, M.D., Ph.D., Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan
    • ,
  • Kazuo Yamada

      Affiliations

    • Laboratory of Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
    • ,
  • Yoshimi Iwayama

      Affiliations

    • Laboratory of Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
    • ,
  • Tomoko Toyota

      Affiliations

    • Laboratory of Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
    • ,
  • Nori Takei

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Yasuhide Iwata

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Katsuaki Suzuki

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Yoshimoto Sekine

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Hideo Matsuzaki

      Affiliations

    • The Osaka-Hamamatsu Joint Research, Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan
    • ,
  • Masayoshi Kawai

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Ko Miyoshi

      Affiliations

    • Department of Brain Science, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan
    • ,
  • Taiichi Katayama

      Affiliations

    • Department of Anatomy and Neuroscience, Hamamatsu University School of Medicine, Hamamatsu, Japan
    • ,
  • Shinsuke Matsuzaki

      Affiliations

    • The Osaka-Hamamatsu Joint Research, Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan
    • Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Japan
    • The 21st Century COE program, Japan
    • ,
  • Kousuke Baba

      Affiliations

    • Department of Anatomy and Development Neurobiology, School of Medicine, Kobe University, Kobe, Japan.
    • ,
  • Akiko Honda

      Affiliations

    • Pharmacology Research Laboratory, Tanabe Seiyaku, Osaka, Japan
    • ,
  • Tsuyoshi Hattori

      Affiliations

    • Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Japan
    • The 21st Century COE program, Japan
    • ,
  • Shoko Shimizu

      Affiliations

    • Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Japan
    • The 21st Century COE program, Japan
    • ,
  • Natsuko Kumamoto

      Affiliations

    • Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Japan
    • The 21st Century COE program, Japan
    • ,
  • Masaya Tohyama

      Affiliations

    • The Osaka-Hamamatsu Joint Research, Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan
    • Department of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, Japan
    • The 21st Century COE program, Japan
    • ,
  • Takeo Yoshikawa

      Affiliations

    • Laboratory of Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
    • ,
  • Norio Mori

      Affiliations

    • Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan

Received 17 April 2007 ,Revised 13 July 2007 ,Accepted 13 July 2007.

References 

  1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436–1442
  2. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–299
  3. Kato T. Molecular genetics of bipolar disorder. Neurosci Res. 2001;40:105–113
  4. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders—cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family. Am J Hum Genet. 2001;69:428–433
  5. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000;9:1415–1423
  6. Millar JK, Christie S, Anderson S, Lawson D, Hsiao-Wei Loh D, Devon RS, et al. Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry. 2001;6:173–178
  7. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990;336:13–16
  8. Devon RS, Anderson S, Teague PW, Burgess P, Kipari TM, Semple CA, et al. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet. 2001;11:71–78
  9. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A. 2005;102:8627–8632
  10. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J, et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet. 2003;12:3151–3159
  11. Kockelkorn TT, Arai M, Matsumoto H, Fukuda N, Yamada K, Minabe Y, et al. Association study of polymorphisms in the 5’ upstream region of human DISC1 gene with schizophrenia. Neurosci Lett. 2004;368:41–45
  12. Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry. 2005;10:758–764
  13. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, et al. Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 2004;75:862–872
  14. Thomson PA, Wray NR, Millar JK, Evans KL, Hellard SL, Condie A, et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry. 2005;10:657–668616
  15. Brandon NJ, Handford EJ, Schurov I, Rain JC, Pelling M, Duran-Jimeniz B, et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: Implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci. 2004;25:42–55
  16. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, et al. Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A. 2003;100:289–294
  17. Millar JK, Christie S, Porteous DJ. Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem Biophys Res Commun. 2003;311:1019–1025
  18. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T, et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry. 2003;8:685–694
  19. Morris JA, Kandpal G, Ma L, Austin CP. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet. 2003;12:1591–1608
  20. Miyoshi K, Asanuma M, Miyazaki I, Diaz-Corrales FJ, Katayama T, Tohyama M, et al. DISC1 localizes to the centrosome by binding to kendrin. Biochem Biophys Res Commun. 2004;317:1195–1199
  21. Yamada K, Nakamura K, Minabe Y, Iwayama-Shigeno Y, Takao H, Toyota T, et al. Association analysis of FEZ1 variants with schizophrenia in Japanese cohorts. Biol Psychiatry. 2004;56:683–690
  22. Baron M. Manic-depression genes and the new millennium: Poised for discovery. Mol Psychiatry. 2002;7:342–358
  23. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: Potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:559–576
  24. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res. 2000;44:151–155
  25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  26. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812
  27. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 2000;Text Revision
  29. Ranade K, Chang MS, Ting CT, Pei D, Hsiao CF, Olivier M, et al. High-throughput genotyping with single nucleotide polymorphisms. Genome Res. 2001;11:1262–1268
  30. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25:115–121
  31. Balczon R, Bao L, Zimmer WE. PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle distribution. J Cell Biol. 1994;124:783–793
  32. Chen D, Purohit A, Halilovic E, Doxsey SJ, Newton AC. Centrosomal anchoring of protein kinase C betaII by pericentrin controls microtubule organization, spindle function, and cytokinesis. J Biol Chem. 2004;279:4829–4839
  33. Dictenberg JB, Zimmerman W, Sparks CA, Young A, Vidair C, Zheng Y, et al. Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome. J Cell Biol. 1998;141:163–174
  34. Diviani D, Langeberg LK, Doxsey SJ, Scott JD. Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain. Curr Biol. 2000;10:417–420
  35. Doxsey SJ, Stein P, Evans L, Calarco PD, Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell. 1994;76:639–650
  36. Kubo A, Sasaki H, Yuba-Kubo A, Tsukita S, Shiina N. Centriolar satellites: Molecular characterization, ATP-dependent movement toward centrioles and possible involvement in ciliogenesis. J Cell Biol. 1999;147:969–980
  37. Rempel N. Centrosomes as scaffolds: The role of pericentrin and protein kinase A-anchoring proteins. Einstein Quart J Biol and Med. 2001;18:54–58
  38. Zimmerman WC, Sillibourne J, Rosa J, Doxsey SJ. Mitosis-specific anchoring of gamma tubulin complexes by pericentrin controls spindle organization and mitotic entry. Mol Biol Cell. 2004;15:3642–3657
  39. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 2001;50:395–406
  40. Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch Gen Psychiatry. 2003;60:359–364
  41. Harrison PJ. The neuropathology of primary mood disorder. Brain. 2002;125:1428–1449
  42. Benes FM. The role of apoptosis in neuronal pathology in schizophrenia and bipolar disorder. Curr Opin Psychiatry. 2004;17:189–190
  43. Beyer JL, Krishnan KR. Volumetric brain imaging findings in mood disorders. Bipolar Disord. 2002;4:89–104
  44. Soares JC. Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder. Int J Neuropsychopharmacol. 2003;6:171–180
  45. Soares JC, Mann JJ. The functional neuroanatomy of mood disorders. J Psychiatr Res. 1997;31:393–432
  46. Blumberg HP, Kaufman J, Martin A, Charney DS, Krystal JH, Peterson BS. Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Ann N Y Acad Sci. 2004;1021:376–383
  47. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59:449–456
  48. Chen BK, Sassi R, Axelson D, Hatch JP, Sanches M, Nicoletti M, et al. Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry. 2004;56:399–405
  49. Crow TJ. Constraints on concepts of pathogenesis (Language and the speciation process as the key to the etiology of schizophrenia). Arch Gen Psychiatry. 1995;52:1011–1014discussion 1019–1024
  50. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: A population-based cohort study. Psychol Med. 1997;27:1311–1323
  51. Harwood AJ. Neurodevelopment and mood stabilizers. Curr Mol Med. 2003;3:472–482
  52. van Os J, Jones P, Lewis G, Wadsworth M, Murray R. Developmental precursors of affective illness in a general population birth cohort. Arch Gen Psychiatry. 1997;54:625–631
  53. Aita VM, Liu J, Knowles JA, Terwilliger JD, Baltazar R, Grunn A, et al. A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. Am J Hum Genet. 1999;64:210–217
  54. Alda M. Pharmacogenetics of lithium response in bipolar disorder. J Psychiatry Neurosci. 1999;24:154–158
  55. Detera-Wadleigh SD, Badner JA, Goldin LR, Berrettini WH, Sanders AR, Rollins DY, et al. Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q. Am J Hum Genet. 1996;58:1279–1285
  56. Detera-Wadleigh SD, Badner JA, Yoshikawa T, Sanders AR, Goldin LR, Turner G, et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet. 1997;74:254–262
  57. Kaneva RP, Chorbov VM, Milanova VK, Kostov CS, Nickolov KI, Chakarova CF, et al. Linkage analysis in bipolar pedigrees adds support for a susceptibility locus on 21q22. Psychiatr Genet. 2004;14:101–106
  58. Kwok JB, Adams LJ, Salmon JA, Donald JA, Mitchell PB, Schofield PR. Nonparametric simulation-based statistical analyses for bipolar affective disorder locus on chromosome 21q22.3. Am J Med Genet. 1999;88:99–102
  59. Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, et al. A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet. 2001;105:189–194
  60. Smyth C, Kalsi G, Curtis D, Brynjolfsson J, O’Neill J, Rifkin L, et al. Two-locus admixture linkage analysis of bipolar and unipolar affective disorder supports the presence of susceptibility loci on chromosomes 11p15 and 21q22. Genomics. 1997;39:271–278
  61. Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, et al. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet. 1994;8:291–296
  62. Yoon IS, Li PP, Siu KP, Kennedy JL, Macciardi F, Cooke RG, et al. Altered TRPC7 gene expression in bipolar-I disorder. Biol Psychiatry. 2001;50:620–626

PII: S0006-3223(07)00672-5

doi: 10.1016/j.biopsych.2007.07.010

Biological Psychiatry
Volume 63, Issue 7 , Pages 678-685 , 1 April 2008

Article Tools

* Image Usage & Resolution